ERCC2 and gastric cancer: For ERCC2 rs1799793, the GA+AA genotypes were found to be significantly associated with a lower risk of mortality from gastric cancer compared with that of the GG genotype (HR, 1.97; 95% CI, 1.28–3.03; P=0.001; Fig. 2).